Kumar Prabhash

44PUBLICATIONS
160CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPharmacogenomicsPreventative health care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (44)

|Jul 09, 2026
Prognostic Reclassification and Survival Outcomes in Intermediate-Risk and Poor-Risk Nonseminomatous Germ Cell Tumors: Single-Institution Experience From Western India.

|Jun 17, 2026
Integrating Metronomic Therapy With Standard Chemotherapy in Advanced Unresectable Head and Neck Cancer: A Randomized Trial Addressing Global Cancer Care Equity (METRO PLUS).

|May 21, 2026
Bladder Adjuvant Radiotherapy: Phase III Multicenter Randomized Controlled Trial of Adjuvant Radiotherapy or Observation for Postcystectomy Muscle-Invasive Bladder Cancer.

|Apr 23, 2026
Low-Dose Versus Standard-Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Multicenter Randomized Phase III Trial.

|Mar 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric Trial.

Vikas Ostwal, Manali Parulekar, Deepali Naughane

|Feb 11, 2026
Lung Connect India Foundation: Pioneering Lung Cancer Advocacy in South Asia and the Urgent Need for Patient-Centered Policy Action.

Akhil Kapoor, Vandana Mahajan, Sanjeev Sharma

Pageof 8

Frequent Collaborators

29 joint publications

Vanita Noronha

16 joint publications

Nandini Sharrel Menon

15 joint publications

Vijay Patil

6 joint publications

Akhil Kapoor